Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Cited by (1,026)

Items 301–400 of 1,026

1. Immunotherapy for Alzheimer’s disease: Key Symposium: Immunotherapy for Alzheimer’s disease
   Morgan, D. · 2011 · Journal of Internal Medicine
2. Chronic Optogenetic Activation Augments Aβ Pathology in a Mouse Model of Alzheimer Disease
   Kaoru Yamamoto, Zen‐ichi Tanei, Tadafumi Hashimoto, Tomoko Wakabayashi, Hiroyuki Okuno, Yasushi Naka, Ofer Yizhar, Lief E. Fenno, Masashi Fukayama, Haruhiko Bito et al. · 2015 · Cell Reports
3. Amyloid β-Protein Toxicity and the Pathogenesis of Alzheimer Disease
   Bruce A. Yankner, Tao Lu · 2008 · Journal of Biological Chemistry
4. Chronic Overproduction of Transforming Growth Factor-β1 by Astrocytes Promotes Alzheimer's Disease-Like Microvascular Degeneration in Transgenic Mice
   Tony Wyss‐Coray, Carol Lin, David A. Sanan, Lennart Mucke, Eliezer Masliah · 2000 · American Journal Of Pathology
5. Learning and Memory in Transgenic Mice Modeling Alzheimer's Disease
   Ashe, Karen Hsiao · 2001 · Learning & Memory
6. Common marmoset as a new model animal for neuroscience research and genome editing technology
   Noriyuki Kishi, Kenya Sato, Erika Sasaki, Hideyuki Okano · 2014 · Development Growth & Differentiation
7. Genetically engineered pigs as models for human disease
   Perleberg, Carolin, Kind, Alexander, Schnieke, Angelika · 2018 · Disease Models & Mechanisms
8. Aβ accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model
   Hurtado, David E., Molina-Porcel, Laura, Iba, Michiyo, Aboagye, Awo K., Paul, Steven M., Trojanowski, John Q., Lee, Virginia M.-Y. · 2010 · The American Journal of Pathology
9. Rodent models for Alzheimer’s disease drug discovery
   Puzzo, Daniela, Gulisano, Walter, Palmeri, Agostino, Arancio, Ottavio · 2015 · Expert Opinion on Drug Discovery
10. Episodic–like memory in animals: psychological criteria, neural mechanisms and the value of episodic–like tasks to investigate animal models of neurodegenerative disease
    Richard Morris · 2001 · Philosophical Transactions of the Royal Society B Biological Sciences
11. Early formation of mature amyloid‐β protein deposits in a mutant APP transgenic model depends on levels of Aβ1–42
    Edward M. Rockenstein, Margaret E. Mallory, Michael Mante, Abyanné Sisk, Eliezer Masliaha · 2001 · Journal of Neuroscience Research
12. Regulation of Amyloid Precursor Protein Cleavage
    Julia Mills, Peter B. Reiner · 1999 · Journal of Neurochemistry
13. Review article What causes alzheimer’s disease?
    Richard A. Armstrong · 2013 · Folia Neuropathologica
14. Drug discovery in dementia: the role of rodent models
    Debby Van Dam, Peter Paul De Deyn · 2006 · Nature Reviews Drug Discovery
15. Updates in Alzheimer's disease: from basic research to diagnosis and therapies
    Enjie Liu, Yao Zhang, Jian–Zhi Wang · 2024 · Translational Neurodegeneration
16. Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: Reduced oxidative stress and preserved mitochondrial function
    Qing Guo, Sylvia Christakos, Nic Robinson, Mark P. Mattson · 1998 · Proceedings of the National Academy of Sciences
17. Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men
    Behrendt, Gwendolyn, Baer, Kristin, Buffo, Annalisa, Curtis, Maurice A., Faull, Richard L., Rees, Mark I., Götz, Magdalena, Dimou, Leda · 2013 · Glia
18. Serotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodomain Secretion
    Nitsch, Roger M., Deng, Meihua, Growdon, John H., Wurtman, Richard J. · 1996 · Journal of Biological Chemistry
19. β-Amyloid precursor polypeptide in SAMP8 mice affects learning and memory
    John Edward Morley, Vijaya B. Kumar, Adonis E. Bernardo, Susan A. Farr, Kayoko Uezu, Nina Tumosa, James F. Flood · 2000 · Peptides
20. Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein
    Niwa, Kiyoshi, Kazama, Ken, Younkin, Steven G., Carlson, George A., Iadecola, Costantino · 2002 · Neurobiology of Disease
21. The Alzheimer family of diseases: Many etiologies, one pathogenesis?
    John Hardy · 1997 · Proceedings of the National Academy of Sciences
22. Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms
    David A. Costa, Jennifer R. Cracchiolo, Adam D. Bachstetter, Tiffany F. Hughes, Kelly R. Bales, Steven M. Paul, Ronald F. Mervis, Gary W. Arendash, Huntington Potter · 2006 · Neurobiology of Aging
23. Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease
    Chen Zhang, Elizabeth M. McNeil, Lindsay Dressler, Robert Siman · 2006 · Experimental Neurology
24. beta-Amyloid toxicity in organotypic hippocampal cultures: Protection by EUK-8, a synthetic catalytic free radical scavenger
    Bruce, A J, Malfroy, B, Baudry, M · 1996 · Proceedings of the National Academy of Sciences
25. Metabolism of amyloid-β peptide and Alzheimer's disease
    Nobuhisa Iwata, Makoto Higuchi, Takaomi C. Saido · 2005 · Pharmacology & Therapeutics
26. Safety, Tolerability, and Changes in Amyloid β Concentrations After Administration of a γ-Secretase Inhibitor in Volunteers
    Eric Siemers, Michael Skinner, Robert A. Dean, Celedon Gonzales, Julie H. Satterwhite, Martin Rhys Farlow, DANIEL K. NESS, Patrick C. May · 2005 · Clinical Neuropharmacology
27. Behavioral assays with mouse models of Alzheimer's disease: Practical considerations and guidelines
    Daniela Puzzo, Linda S. Lee, Agostino Palmeri, Giorgio Calabrese, Ottavio Arancio · 2014 · Biochemical Pharmacology
28. Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level
    Sadleir, Katherine R, Eimer, William A, Cole, Sarah L, Vassar, Robert · 2015 · Molecular Neurodegeneration
29. Amyloid-Associated Neuron Loss and Gliogenesis in the Neocortex of Amyloid Precursor Protein Transgenic Mice
    Bondolfi, Luca, Calhoun, Michael, Ermini, Florian, Kuhn, H. Georg, Wiederhold, Karl-Heinz, Walker, Lary, Staufenbiel, Matthias, Jucker, Mathias · 2002 · The Journal of Neuroscience
30. Mouse Models of Alzheimer’s Disease
    Yokoyama, Miyabishara, Kobayashi, Honoka, Tatsumi, Lisa, Tomita, Taisuke · 2022 · Frontiers in Molecular Neuroscience
31. Soluble oligomers of amyloid-β peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway
    Catherine Malaplate, Sabrina Florent‐Béchard, Ihsen Youssef, Violette Koziel, Isabelle Sponne, Badreddine Kriem, Brigitte Leininger‐Muller, J L Olivier, Thierry Oster, Thierry Pillot · 2006 · Neurobiology of Disease
32. Cognitive correlates of Aβ deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes
    Howlett, David R, Richardson, Jill C, Austin, Angela, Parsons, Andrew A, Bate, Simon T, Davies, D.Ceri, Gonzalez, M.Isabel · 2004 · Brain Research
33. Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain
    Vandita Kakkar, Indu Pal Kaur · 2011 · Food and Chemical Toxicology
34. Knowledge domain and emerging trends in Alzheimer’s disease: a scientometric review based on CiteSpace analysis
    Shuo Liu, Ya-Ping Sun, Xu-Ling Gao, Yi Sui · 2019 · Neural Regeneration Research
35. In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease
    Daniel Skovronsky, Bin Zhang, Mei‐Ping Kung, Hank F. Kung, John Q. Trojanowski, Virginia M.‐Y. Lee · 2000 · Proceedings of the National Academy of Sciences
36. Uptake, Degradation, and Release of Fibrillar and Soluble Forms of Alzheimer's Amyloid β-Peptide by Microglial Cells
    Chung, Haeyong, Brazil, Melanie I., Soe, Thwe Thwe, Maxfield, Frederick R. · 1999 · Journal of Biological Chemistry
37. Structural studies of soluble oligomers of the alzheimer β-amyloid peptide
    T.H. Jackson Huang, Yang Dun-Sheng, Nicholas Peter Plaskos, Sandy Go, Christopher M. Yip, Paul E. Fraser, Avijit Chakrabartty · 2000 · Journal of Molecular Biology
38. Amyloid β-protein toxicity and oxidative stress in Alzheimer's disease
    Christian Behl · 1997 · Cell and Tissue Research
39. Formation of stable complexes between two Alzheimer's disease gene products: Presenilin-2 and β-amyloid precursor protein
    Andreas Weidemann, Krzysztof Paliga, Ulrike Dürrwang, Christian Czech, Genevieve M. Evin, Colin Louis Masters, Konrad T. Beyreuther · 1997 · Nature Medicine
40. Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins
    Huynh, Tien-Phat V., Davis, Albert A., Ulrich, Jason D., Holtzman, David M. · 2017 · Journal of Lipid Research
41. Age-Related Impairment of Synaptic Transmission But Normal Long-Term Potentiation in Transgenic Mice that Overexpress the Human APP695SWE Mutant Form of Amyloid Precursor Protein
    Stephen M. Fitzjohn, Robin A. Morton, Frederick M. Kuenzi, Thomas W. Rosahl, Mark S. Shearman, Huw D. Lewis, David Smith, David S. Reynolds, Ceri H. Davies, Graham L. Collingridge et al. · 2001 · Journal of Neuroscience
42. G Protein-Mediated Neuronal DNA Fragmentation Induced by Familial Alzheimer's Disease-Associated Mutants of APP
    Tomoki Yamatsuji, Takashi Matsui, Takashi Okamoto, Katsumi Komatsuzaki, Shizu Takeda, Hiroaki Fukumoto, Takeshi Iwatsubo, Nobuhiro Suzuki, Asano Asami-Odaka, Scott Ireland et al. · 1996 · Science
43. Transgenic models of Alzheimer’s disease: Learning from animals
    Tara L. Spires‐Jones, Bradley T. Hyman · 2005 · NeuroRx
44. Role of EGFR in the Nervous System
    Roberta Romanò, Cecilia Bucci · 2020 · Cells
45. Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex
    Tina M. Rees · 2003 · Neurobiology of Aging
46. Axonal degeneration in Alzheimer's disease: When signaling abnormalities meet the axonal transport system
    Nicholas M. Kanaan, Gustavo F. Pigino, Scott T. Brady, Orly Lazarov, Lester I. Binder, Gerardo A. Morfini · 2012 · Experimental Neurology
47. Recognition Sequence Design for Peptidyl Modulators of β-Amyloid Aggregation and Toxicity
    Monica M. Pallitto, Jyothi Ghanta, Peter Heinzelman, Laura L. Kiessling, Regina M. Murphy · 1999 · Biochemistry
48. Gene delivery of human apolipoprotein E alters brain Aβ burden in a mouse model of Alzheimer's disease
    Dodart, Jean-Cosme, Marr, Robert A., Koistinaho, Milla, Gregersen, Beth M., Malkani, Seema, Verma, Inder M., Paul, Steven M. · 2005 · Proceedings of the National Academy of Sciences
49. Anti-A 42- and anti-A 40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model
    Yona Levites · 2005 · Journal of Clinical Investigation
50. The Potent BACE1 Inhibitor LY2886721 Elicits Robust Central Aβ Pharmacodynamic Responses in Mice, Dogs, and Humans
    May, Patrick C., Willis, Brian A., Lowe, Stephen L., Dean, Robert A., Monk, Scott A., Cocke, Patrick J., Audia, James E., Boggs, Leonard N., Borders, Anthony R., Brier, Richard A. et al. · 2015 · The Journal of Neuroscience
51. Alzheimer’s Disease And Inflammation: A Review Of Cellular And Therapeutic Mechanisms
    Glenda Margaret Halliday, Stephen R. Robinson, Claire E. Shepherd, Jillian J. Kril · 2000 · Clinical and Experimental Pharmacology and Physiology
52. Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein
    Zhang, Fangyi, Eckman, Chris, Younkin, Steven, Hsiao, Karen K., Iadecola, Costantino · 1997 · The Journal of Neuroscience
53. Modeling Alzheimer’s disease in transgenic rats
    Sonia Do Carmo, A. Claudio Cuello · 2013 · Molecular Neurodegeneration
54. Noradrenaline deficiency in brain increases β-amyloid plaque burden in an animal model of Alzheimer's disease
    Sergey Kalinin, Vitaliy Gavrilyuk, Paul E. Polak, Robert Vasser, Jie Janet Zhao, Michael Thomas Heneka, Douglas L. Feinstein · 2006 · Neurobiology of Aging
55. Synaptic Vulnerability in Neurodegenerative Disease
    Thomas M. Wishart, Simon H. Parson, Thomas Henry Gillingwater · 2006 · Journal of Neuropathology & Experimental Neurology
56. Region‐specific reduction of Aβ‐degrading endopeptidase, neprilysin, in mouse hippocampus upon aging
    Nobuhisa Iwata, Yoshie Takaki, Shinjiro Fukami, Satoshi Tsubuki, Takaomi C. Saido · 2002 · Journal of Neuroscience Research
57. Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites.
    David G. Cook, J C Sung, Todd Eliot Golde, Kevin M. Felsenstein, Bogusław S. Wójczyk, Rudolph E. Tanzi, John Q. Trojanowski, V M Lee, Robert W. Doms · 1996 · Proceedings of the National Academy of Sciences
58. The X11α protein slows cellular amyloid precursor protein processing and reduces Aβ40 and Aβ42 secretion
    Borg, Jean-Paul, Yang, Yunning, De Taddéo-Borg, Mylène, Margolis, Ben, Turner, R. Scott · 1998 · Journal of Biological Chemistry
59. Expression in brain of amyloid precursor protein mutated in the alpha‐secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice.
    Moechars, D., Lorent, K., De Strooper, B., Dewachter, I., Van Leuven, F. · 1996 · The EMBO Journal
60. Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: A magnetic resonance microscopy and stereologic analysis
    Jeffrey M. Redwine, Barry E. Kosofsky, Russell E. Jacobs, Dora Games, John F. Reilly, John H. Morrison, Warren G. Young, Floyd E. Bloom · 2003 · Proceedings of the National Academy of Sciences
61. Alzheimer Disease
    Mark A. Smith · 1998 · International review of neurobiology
62. PS2APP Transgenic Mice, Coexpressing hPS2mut and hAPPswe, Show Age-Related Cognitive Deficits Associated with Discrete Brain Amyloid Deposition and Inflammation
    John Grayson Richards, Guy A. Higgins, Abdel‐Mouttalib Ouagazzal, Laurence Ozmen, James N.C. Kew, Bernd Bohrmann, Pari Malherbe, Manfred Brockhaus, Hansruedi Loetscher, Christian Czech et al. · 2003 · Journal of Neuroscience
63. Age-Dependent Neuronal and Synaptic Degeneration in Mice Transgenic for the C Terminus of the Amyloid Precursor Protein
    Mary Lou Oster‐Granite, Donna L. McPhie, Jane Greenan, Rachael L. Neve · 1996 · Journal of Neuroscience
64. Correlation between cognitive deficits and Aβ deposits in transgenic APP+PS1 mice
    Marcia N. Gordon, David L King, David M. Diamond, Paul T. Jantzen, Kristal W. Boyett, Caroline E. Hope, Jaime M. Hatcher-Martin, Giovanni DiCarlo, W.Paul E Gottschall, David Morgan et al. · 2001 · Neurobiology of Aging
65. Cerebral Microvascular Amyloid β Protein Deposition Induces Vascular Degeneration and Neuroinflammation in Transgenic Mice Expressing Human Vasculotropic Mutant Amyloid β Precursor Protein
    Jianting Miao, Feng Xu, Judianne Davis, Irene Otte‐Höller, Marcel M. Verbeek, William E. Van Nostrand · 2005 · American Journal Of Pathology
66. Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy
    Małgorzata Marjańska, Geoffrey L. Curran, Thomas M. Wengenack, Pierre‐Gilles Henry, Robin Bliss, Joseph F. Poduslo, Clifford R. Jack, Kǎmil Uǧurbil, Michael Garwood · 2005 · Proceedings of the National Academy of Sciences
67. Accelerating Alzheimer’s therapeutic development: The past and future of clinical trials
    Boxer, Adam L., Sperling, Reisa · 2023 · Cell
68. Electromagnetic Controlled Cortical Impact Device for Precise, Graded Experimental Traumatic Brain Injury
    David L. Brody, Christine Mac Donald, Chad C. Kessens, Carla M. Yuede, Maia Parsadanian, Mike Spinner, Eddie Kim, Katherine E. Schwetye, David M. Holtzman, Philip V. Bayly · 2007 · Journal of Neurotrauma
69. Deletion of the 7 Nicotinic Acetylcholine Receptor Gene Improves Cognitive Deficits and Synaptic Pathology in a Mouse Model of Alzheimer's Disease
    Gustavo Dziewczapolski, Michał Głogowski, E. Masliah, Stephen F. Heinemann · 2009 · Journal of Neuroscience
70. p25/Cyclin-Dependent Kinase 5 Induces Production and Intraneuronal Accumulation of Amyloid βIn Vivo
    Jonathan C. Cruz, Dohoon Kim, Lily Y. Moy, Matthew M. Dobbin, Xiaoyan Sun, Roderick Terry Bronson, Li‐Huei Tsai · 2006 · Journal of Neuroscience
71. Transgenic Expression of the Shortest Human Tau Affects Its Compartmentalization and Its Phosphorylation as in the Pretangle Stage of Alzheimer's Disease
    Jean‐Pierre Brion, Günter L. Tremp, Jean‐Noël Octave · 1999 · American Journal Of Pathology
72. Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes
    Wong, Tak Pan, Debeir, Thomas, Duff, Karen, Cuello, A. Claudio · 1999 · The Journal of Neuroscience
73. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling
    Steffen Roßner · 1998 · Progress in Neurobiology
74. Mouse models of human disease. Part II: recent progress and future directions.
    Mary A. Bedell, David A. Largaespada, Nancy A. Jenkins, Neal G. Copeland · 1997 · Genes & Development
75. β-Amyloid peptides as direct cholinergic neuromodulators: a missing link?
    Daniel S. Auld, Satyabrata Kar, Rémi Quirion · 1998 · Trends in Neurosciences
76. Animal models of Alzheimer's disease and evaluation of anti-dementia drugs
    Kiyofumi Yamada, Toshitaka Nabeshima · 2000 · Pharmacology & Therapeutics
77. Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injury
    David L. Brody, David M. Holtzman · 2005 · Experimental Neurology
78. Anti-Aβ antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice
    Brendza, Robert P., Bacskai, Brian J., Cirrito, John R., Simmons, Kelly A., Skoch, Jesse M., Klunk, William E., Mathis, Chester A., Bales, Kelly R., Paul, Steven M., Hyman, Bradley T. et al. · 2005 · Journal of Clinical Investigation
79. Apoptosis and Alzheimer's disease
    Christian Behl · 2000 · Journal of Neural Transmission
80. Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain
    Paterna, J-C, Moccetti, T, Mura, A, Feldon, J, Büeler, H · 2000 · Gene Therapy
81. Pronuclear injection for the production of transgenic mice
    Lars Matthias Ittner, Jürgen Götz · 2007 · Nature Protocols
82. Overview of Alzheimer’s Disease and Some Therapeutic Approaches Targeting Aβ by Using Several Synthetic and Herbal Compounds
    Sandeep Kumar Singh, Saurabh Srivastav, Amarish Kumar Yadav, Saripella Srikrishna, George L. Perry · 2015 · Oxidative Medicine and Cellular Longevity
83. Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity
    Thomas Arendt · 2003 · Progress in Neurobiology
84. Calcium, free radicals and excitotoxins in neuronal apoptosis
    Stuart A. Lipton, Pierluigi Nicotera · 1998 · Cell Calcium
85. Progression of Amyloid Pathology to Alzheimer's Disease Pathology in an Amyloid Precursor Protein Transgenic Mouse Model by Removal of Nitric Oxide Synthase 2
    Donna M. Wilcock, Matthew R. Lewis, William E. Van Nostrand, Judianne Davis, Mary Lou Previti, Nastaran Gharkholonarehe, Michael Peter Vitek, Carol A. Colton · 2008 · Journal of Neuroscience
86. Cerebral Amyloid Induces Aberrant Axonal Sprouting and Ectopic Terminal Formation in Amyloid Precursor Protein Transgenic Mice
    Amie L. Phinney, Thomas Deller, Martina Stalder, Michael E. Calhoun, Michael Frotscher, Bernd Sommer, Matthias Staufenbiel, Mathias Jucker · 1999 · Journal of Neuroscience
87. Using Knockout and Transgenic Mice to Study Neurophysiology and Behavior
    Marina R. Picciotto, Kevin Wickman · 1998 · Physiological Reviews
88. Biology of Aβ Amyloid in Alzheimer's Disease
    Thomas Wısnıewskı, Jorge A. Ghiso, Blas Frangione · 1997 · Neurobiology of Disease
89. The p75 Neurotrophin Receptor Promotes Amyloid-β(1-42)-Induced Neuritic Dystrophy<i>In Vitro</i>and<i>In Vivo</i>
    Knowles, Juliet K., Rajadas, Jayakumar, Nguyen, Thuy-Vi V., Yang, Tao, LeMieux, Melburne C., Vander Griend, Lilith, Ishikawa, Chihiro, Massa, Stephen M., Wyss-Coray, Tony, Longo, Frank M. · 2009 · The Journal of Neuroscience
90. Fibrillar Amyloid-β Peptides Kill Human Primary Neurons via NADPH Oxidase-mediated Activation of Neutral Sphingomyelinase
    Arundhati Jana, Kalipada Pahan · 2004 · Journal of Biological Chemistry
91. Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene.
    David M. A. Mann, Takeshi Iwatsubo, Yasuo Ihara, Nigel J. Cairns, Peter L Lantos, Nenad Bogdanović, Lars Lannfelt, Bengt G. Winblad, Marion L. C. Maat–Schieman, Martin N. Rossor · 1996 · Europe PMC (PubMed Central)
92. Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease
    George L. Perry, Rudy J. Castellani, Keisuke Hirai, Mark A. Smith · 1998 · Journal of Alzheimer s Disease
93. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid β peptides but not on plaque formation
    Buttini, Manuel, Yu, Gui-Qiu, Shockley, Kristina, Huang, Yadong, Jones, Brian, Masliah, Eliezer, Mallory, Margaret, Yeo, Tracy, Longo, Frank M., Mucke, Lennart · 2002 · The Journal of Neuroscience
94. Lipid Alterations in the Earliest Clinically Recognizable Stage of Alzheimers Disease: Implication of the Role of Lipids in the Pathogenesis of Alzheimers Disease
    Han, Xianlin · 2005 · Current Alzheimer Research
95. Lentiviral Vectors as a Gene Delivery System in the Mouse Midbrain: Cellular and Behavioral Improvements in a 6-OHDA Model of Parkinson's Disease Using GDNF
    Jean‐Charles Bensadoun, Nicole Déglon, Jack Tseng, Jean‐Luc Ridet, Anne D. Zurn, Patrick Aebischer · 2000 · Experimental Neurology
96. Understanding Aspects of Aluminum Exposure in A lzheimer's Disease Development
    Ramesh J. L. Kandimalla, Jayalakshmi Vallamkondu, Edwin B. Corgiat, Kiran Dip Gill · 2015 · Brain Pathology
97. Amyloid Precursor Proteins Inhibit Heme Oxygenase Activity and Augment Neurotoxicity in Alzheimer's Disease
    Masaaki Takahashi, Sylvain Doré, Christopher D. Ferris, Taisuke Tomita, Akira Sawa, Herman Wolosker, David Borchelt, Takeshi Iwatsubo, Seong‐Hun Kim, Gopal Thinakaran et al. · 2000 · Neuron
98. Oligomerization of Endogenous and Synthetic Amyloid β-Protein at Nanomolar Levels in Cell Culture and Stabilization of Monomer by Congo Red
    Marcia Berman Podlisny, Dominic M. Walsh, Patricia Amarante, Beth L. Ostaszewski, Evelyn R. Stimson, John E. Maggio, David B. Teplow, Dennis J. Selkoe · 1998 · Biochemistry
99. From Chronic Cerebral Hypoperfusion to Alzheimer-Like Brain Pathology and Neurodegeneration
    Zhao, Yang, Gong, Cheng-Xin · 2015 · Cellular and Molecular Neurobiology
100. Amyloid Phenotype Characterization of Transgenic Mice Overexpressing both Mutant Amyloid Precursor Protein and Mutant Presenilin 1 Transgenes
     Eileen M. McGowan, Sunny Sanders, Takeshi Iwatsubo, A. Takeuchi, Takaomi C. Saido, Cindy Zehr, Xin Yu, Sacha Uljon, R. Wang, David M. A. Mann et al. · 1999 · Neurobiology of Disease